---
layout: minimal-medicine
nav_exclude: true
title: Ixabepilone
---

# Ixabepilone

**Generic Name:** Ixabepilone

**Usage:** Ixabepilone is a chemotherapy drug used to treat metastatic breast cancer. Specifically, it's used in patients who have already received at least two other chemotherapy regimens for their metastatic disease, including an anthracycline and a taxane (unless contraindicated).  It's sometimes used in combination with other treatments.  It's important to note that this is not a first-line treatment for breast cancer.

**Side Effects:** Ixabepilone can cause a wide range of side effects, some common and others rare.  The most common side effects include:

* **Neuropathy (nerve damage):** This is a frequent and potentially dose-limiting side effect, manifesting as tingling, numbness, pain, or burning sensations in the hands and feet.
* **Fatigue:** Feeling unusually tired or weak.
* **Alopecia (hair loss):** Although not always severe.
* **Nausea and vomiting:** These can often be managed with antiemetic medications.
* **Diarrhea:**  Can be mild to moderate.
* **Low blood cell counts (neutropenia, thrombocytopenia, anemia):** This increases the risk of infection, bleeding, and fatigue.
* **Fluid retention (edema):** Swelling in the legs, ankles, or feet.
* **Infections:** Due to the immunosuppressive effects of the drug.
* **Increased liver enzymes:**  Monitored through blood tests.
* **Hypersensitivity reactions:**  Allergic reactions, ranging from mild rash to severe anaphylaxis (rare).


**Severe side effects, while less common, are possible and require immediate medical attention. These can include:**

* **Severe allergic reactions**
* **Severe neutropenia (very low white blood cell count)**
* **Severe thrombocytopenia (very low platelet count)**
* **Severe liver dysfunction**


**How it Works:** Ixabepilone is a taxane derivative, but unlike paclitaxel or docetaxel, it's not a microtubule stabilizer.  Instead, it works by inhibiting the depolymerization of microtubules (preventing their breakdown).  This disruption of microtubule dynamics interferes with cell division and ultimately leads to cancer cell death.  The exact mechanism is complex and involves interactions with several cellular components.

**FAQs:**

* **Q: How is ixabepilone administered?** A: Ixabepilone is administered intravenously (IV) over a period of approximately 30 minutes.
* **Q: How often is ixabepilone given?** A:  The usual dosage schedule is 40 mg/mÂ² given every 3 weeks.  However, the specific dosage and schedule will be determined by a physician based on the patient's individual needs and tolerance.
* **Q: What are the precautions before taking ixabepilone?** A:  Patients should inform their doctor of any pre-existing medical conditions, especially liver or kidney problems, or any allergies.  Pregnancy and breastfeeding are contraindications.
* **Q:  What are the interactions with other drugs?** A: Ixabepilone may interact with other medications, including other chemotherapy drugs, so it is crucial to inform your doctor about all medications you are taking.
* **Q: What should I do if I experience side effects?** A: Report any side effects to your doctor or healthcare provider immediately.  They can help manage the side effects and adjust the treatment plan if necessary.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized information based on your specific situation and medical history.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.